Cargando…
Outcomes of Transcutaneous Retrobulbar Amphotericin B in Rhino-Orbital-Cerebral Mucormycosis Among Patients Recovering From COVID-19: A Preliminary Experience
Background In this study, we aimed to assess the outcomes of transcutaneous retrobulbar injection of amphotericin B (TRAMB) in rhino-orbital-cerebral mucormycosis (ROCM) among patients recovering from coronavirus disease 2019 (COVID-19). Methodology This retrospective study was conducted at a tertia...
Autores principales: | Sinha, Shivani, Kumar, Vidya B, Kumar, Abhay, Singh, Vivek, Anand, Abhishek, Kusumesh, Rakhi, Mishra, Sarita, Raj, Pragati, Sinha, Bibhuti P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455078/ https://www.ncbi.nlm.nih.gov/pubmed/36106303 http://dx.doi.org/10.7759/cureus.27817 |
Ejemplares similares
-
Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis
por: Singh, Prabhakar, et al.
Publicado: (2022) -
Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19
por: Shakrawal, Jyoti, et al.
Publicado: (2022) -
Risk Factors of Rhino Orbital Mucormycosis
por: Patade, Yugandhara, et al.
Publicado: (2022) -
Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B
por: Safi, Mustafa, et al.
Publicado: (2020) -
Combination endoscopic surgical debridement and transcutaneous retrobulbar amphotericin B for acute rhino-orbital-cerebral aspergillosis
por: Zhang, Kevin X., et al.
Publicado: (2023)